Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Christopher Happ

Orthopaedic Surgery of the Spine Weatherford, TX Doctor of Osteopathy

NPI 1154561702 CMS profile 1294728

1429 Clear Lake Rd Ste 100, Weatherford, TX 76086

Open in the dashboard

General payments

$104,749

90 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christopher Happ of Weatherford, TX is reported in the CMS Open Payments database as having received $104,749 across 90 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 77th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $508 17
2024 General $8,493 10
2023 General $30,906 9
2022 General $27,820 11
2021 General $28,652 19
2020 General $4,270 7
2019 General $4,099 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Happ
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Christopher Happ were reported at $508. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Christopher Happ Orthopaedic Surgery of the Spine median Middle half National median
2019 $4,099 $2,106 $337–$18,608 $163
2020 $4,270 $1,213 $156–$15,082 $114
2021 $28,652 $1,834 $271–$15,617 $132
2022 $27,820 $2,015 $320–$17,036 $149
2023 $30,906 $1,925 $336–$14,599 $160
2024 $8,493 $2,110 $341–$12,483 $164
2025 $508 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Nvision Biomedical Technologies, Inc. $93,890 11 payments
  2. Kyocera Medical Technologies, Inc. $3,578 6 payments
  3. HD LifeSciences LLC $3,379 3 payments
  4. Centinel Spine, LLC $1,128 8 payments
  5. Nevro Corp. $866 19 payments
  6. Camber Spine Technologies $613 3 payments
  7. Globus Medical, Inc. $352 8 payments
  8. Providence Medical Technology, Inc. $172 3 payments
  9. Osseus Fusion Systems, LLC $150 1 payment
  10. Intrinsic Therapeutics $147 10 payments
  11. Other $474 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $88,863 8 payments
  2. Consulting Fee $11,104 6 payments
  3. Food and Beverage $3,233 69 payments
  4. Travel and Lodging $1,550 7 payments
Products named General payments · program years 2019–2025
  1. Focus $31,495 4 payments
  2. Foot and Ankle $30,514 2 payments
  3. Spine products $27,365 2 payments
  4. Senza Spinal Cord Stimulation System $711 14 payments
  5. PRODISC L $660 3 payments
  6. MIS Pedicle $516 2 payments
  7. PRODISC C $215 2 payments
  8. PRODISC C SK $205 2 payments
  9. RISE-L $149 2 payments
  10. BARRICAID ACD (ANNULAR CLOSURE DEVICE) $147 10 payments
  11. Other $1,008 39 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

1,584

Median for Orthopedic Surgery: 203

Drug cost

$29,471

Median for Orthopedic Surgery: $1,433

Branded share of claims

5.5%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 340 $11,544
Tizanidine Hcl Generic 465 $6,667
Gabapentin Generic 237 $3,028
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 71 $2,082
Etodolac Generic 67 $1,671
Methocarbamol Generic 102 $1,464
Pregabalin Generic 68 $1,018
Cyclobenzaprine Hcl Generic 37 $867
Acetaminophen-Codeine Acetaminophen With Codeine Brand 16 $508
Cephalexin Generic 48 $205

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$183,243

Medicare's payments for the services billed

Medicare patients

415

Average age 73

Services billed

985

214 women, 201 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 31%
Ischemic heart disease 31%
Chronic kidney disease 24%
Depression 24%
COPD 21%
Osteoporosis 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

90 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record